Illinois CancerCare
Hematology
Dr. Paul A. Fishkin, MD
|
|
Give Review
Doctor Paul A. Fishkin, MD practices Hematology. He went to Creighton University School of Medicine. Creighton University School of Medicine is ranked 79 in research and 78 in primary care medicine He has 1 awards "CMS Meaningful Use Stage 1 Certification". Paul Fishkin is a published doctor and has 14 publications published. The lastest was: 'A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.' He accepts all Medicare patients.
Publications
- Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced Carcinoma of the esophagus or gastroesophageal junction.
- Treatment recommendations for radioimmunotherapy in follicular Lymphoma: a consensus conference report.
- Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment G...
- Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central C...
- Fulvestrant in women with advanced breast Cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032.
- Phase II trial of dolastatin-10 in patients with advanced breast Cancer.
- CPT-11 for bile-duct and gallbladder carcinoma: a phase II North Central Cancer Treatment Group (NCCTG) study.
- Comparison of lymphoid neoplasm classification. A blinded study between a community and an academic setting.
- Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck Cancer.
- Utility of flow cytometry immunophenotyping for the diagnosis and classification of Lymphoma in community hospital clinical needle aspiration/biopsies.
- Relative frequencies and sites of presentation of lymphoid neoplasms in a community hospital according to the revised European-American classification.
- A phase II study of 9-aminocamptothecin in advanced non-small-cell lung Cancer.
- Munchausen's syndrome and Cancer.
Schools
Creighton University School Of Medicine
University Okla
Letterman Army Med Center
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Oklahoma Health Sciences Center -
Creighton University School of Medicine
Drug Facts
| NPI NUMBER | 1063411379 | |
| NPPES Provider LastName | FISHKIN | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 616157822 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 2309.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 390.0 | |
| Percent Opioid Claims | 16.89 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063411379 |
| Last Name Of The Provider | FISHKIN |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Francois J. Geoffroy, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Diane J. Prager, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nguyet A. Le-Lindquister, MD |